Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up
Author(s) -
Herbert Nägele,
Hans-Martin Stubbe,
C.A. Nienaber,
W. Rödiger
Publication year - 1998
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.1998.1152
Subject(s) - medicine , ejection fraction , revascularization , canadian cardiovascular society , coronary artery disease , angina , cardiology , surgery , myocardial infarction , heart failure
Transmyocardial laser revascularization is a new therapeutic option for end-stage coronary artery disease if no other cardiological or cardiosurgical intervention is possible. Data are few on how patients fare after more than 1 year follow-up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom